1. Home
  2. RYTM
  3. RYTM News

Latest Rhythm Pharmaceuticals Inc. (RYTM) News on September 6, 2025

FDA Priority Review for Setmelanotide in Hypothalamic Obesity Might Change The Case For Investing In Rhythm Pharmaceuticals (RYTM)

Simply Wall St.

16 days ago

FDA Priority Review for Setmelanotide in Hypothalamic Obesity Might Change The Case For Investing In Rhythm Pharmaceuticals (RYTM)

Thomson Reuters StreetEvents

6 months ago

Q4 2024 Rhythm Pharmaceuticals Inc Earnings Call

Share on Social Networks: